VeroScience: VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) And Neurophysiological Investigations Of Brain Dopamine Regulation Of Metabolism With Eight Papers Presented At The 2015 American Diabetes Association Conference

TIVERTON, R.I., June 6, 2015 /PRNewswire/ --www.veroscience.com/" target"_blank" rel"nofollow">VeroScience, Inc. is pleased to be participating at the American Diabetes Association's 75th Scientific Sessions in Boston, Mass with additional clinical...